Skip to main content
. 2022 Jun 21;22:227. doi: 10.1186/s12883-022-02754-7

Table 3.

The relationships between possible risk factors and prognostic factors and mRS at 1 year-follow up

Baseline mRS mRS at 1 year-follow up Percent change (%) Patients with mRS > 2 / Total patients β a (SE) P-value
Sex
 Female (ref.) 2.2 ± 1.3 1. ± 1.2 9.6 ± 34.2 8/19 -0.1(0.6) 0.824
 Male 2.7 ± 1.2 2.0 ± 1.3 26.3 ± 35.7 9/28
Age
  < 45 (ref.) 2.8 ± 1.2 2.1 ± 1.2 24.3 ± 32.2 12/31 1.8(0.4)  < 0.001
  ≥ 45 2.0 ± 1.2 1.7 ± 1.3 10.4 ± 41.2 5/16
Vessel
 Carotid (ref.) 2.4 ± 1.3 2.0 ± 1.2 10.7 ± 31.5 11/28 0.5(0.6) 0.341
 Vertebral 2.7 ± 1.2 1.9 ± 1.3 32.7 ± 38.3 6/19
Side
 Right (ref.) 2.6 ± 1.3 2.0 ± 1.4 21.3 ± 43.4 11/26 0.04(0.5) 0.948
 Left 2.4 ± 1.2 1.9 ± 1.1 17.4 ± 23.8 6/21
Headache
 No (ref.) 2.8 ± 1.1 2.6 ± 1.0 2.3 ± 35.1 8/14 -1.2(0.6) 0.058
 Yes 2.4 ± 1.3 1.6 ± 1.2 26.9 ± 33.9 9/33
Neck pain
 No (ref.) 2.6 ± 1.4 2.2 ± 1.4 11.6 ± 35.7 13/27 -0.7(0.6) 0.193
 Yes 2.3 ± 1.1 1.6 ± 1.0 30.4 ± 33.7 4/20
Progression of symptoms
 No (ref.) 2.5 ± 1.3 1.8 ± 1.3 22.0 ± 38.4 13/38 1.0(0.7) 0.136
 Yes 2.5 ± 1.1 2.3 ± 1.2 9.2 ± 18.8 4/9
Addiction
 No (ref.) 2.5 ± 1.3 1.9 ± 1.2 20.7 ± 36.5 14/38 0.6(0.7) 0.391
 Yes 2.3 ± 1.3 2.0 ± 1.5 14.8 ± 33.8 3/9
Alcohol
 No (ref.) 2.5 ± 1.3 1.9 ± 1.2 18.6 ± 34.6 16/44 -0.1(1.2) 0.964
 Yes 2.3 ± 0.5 1.6 ± 1.5 33.3 ± 57.7 1/3
Smoking
 No (ref.) 2.6 ± 1.3 2.0 ± 1.2 17.2 ± 34.2 15/37 -0.3(0.7) 0.695
 Yes 2.1 ± 1.1 1.5 ± 1.3 28.3 ± 41.6 2/10
OCP use
 No (ref.) 2.2 ± 1.4 1.8 ± 1.2 10.2 ± 35.2 7/18 N/A N/A
 Yes 3.0 ± 0.0 3.0 ± 0.0 0.0 ± 0.0 1/1
Infection
 No (ref.) 2.6 ± 1.3 2.0 ± 1.3 20.2 ± 36.7 17/43 0.5(0.9) 0.604
 Yes 1.5 ± 0.5 1.2 ± 0.5 12.5 ± 25.0 0/4
Exercise
 No (ref.) 2.5 ± 1.3 2.0 ± 1.2 16.9 ± 33.6 16/44 -3.1(1.5) 0.037*
 Yes 3.0 ± 1.0 1.3 ± 1.5 58.3 ± 52.0 1/3
Cough
 No (ref.) 2.6 ± 1.3 2.0 ± 1.3 20.2 ± 36.7 16/44 0.5(0.9) 0.604
 Yes 1.5 ± 0.5 1.2 ± 0.5 12.5 ± 25.0 1/3
History of trauma
 No (ref.) 2.4 ± 1.2 1.9 ± 1.2 16.9 ± 27.5 12/34 -1.0(0.7) 0.167
 Yes 2.8 ± 1.4 1.9 ± 1.3 26.6 ± 52.3 5/13
Trauma type
 Minor (ref.) 2.2 ± 1.7 2.2 ± 1.7 -12.5 ± 62.9 2/4 N/A N/A
 Major 3.1 ± 1.2 1.7 ± 1.3 44.0 ± 38.9 3/9
Vasculitis test result
 Negative (ref.) 2.8 ± 1.2 2.2 ± 1.3 22.0 ± 29.7 9/20 -0.9(1.6) 0.574
 Positive 2.5 ± 0.7 1.5 ± 0.7 33.3 ± 47.1 0/2
Homocysteine test result
 Negative (ref.) 2.8 ± 1.2 2.1 ± 1.3 25.4 ± 31.7 7/19 0.9(1.1) 0.425
 Positive 3.0 ± 1.0 2.6 ± 0.5 8.3 ± 14.4 2/3
Previous headache/ Migraine
 No (ref.) 2.6 ± 1.2 2.0 ± 1.2 18.6 ± 36.3 15/37 -0.2(0.7) 0.781
 Yes 2.3 ± 1.4 1.7 ± 1.5 23.3 ± 35.3 2/10
New headache
 No (ref.) 2.4 ± 1.2 2.0 ± 1.3 15.3 ± 36.7 13/31 -0.5(0.6) 0.383
 Yes 2.7 ± 1.3 1.8 ± 1.3 27.9 ± 35.7 4/16
Change in the pattern of headaches
 No (ref.) 1.6 ± 1.1 1.0 ± 1.0 26.6 ± 43.4 0/5 N/A N/A
 Yes 3.0 ± 1.4 2.4 ± 1.6 20.0 ± 29.8 2/5
Recanalization
 No (ref.) 2.2 ± 1.2 1.9 ± 1.5 13.6 ± 48.7 4/11 0.02(0.7) 0.978
 Yes 2.5 ± 1.4 2.0 ± 1.3 19.0 ± 29.5 10/25
Medication
 Double anti platelet (ref.) 2.5 ± 1.2 1.9 ± 1.2 21.0 ± 38.2 14/37 0.3(0.7) 0.617
 Anti-coagulant 2.5 ± 1.6 2.0 ± 1.5 14.1 ± 25.4 3/10

mRS Modified Rankin scale, OCP Oral Contraceptive Pill, SE Standard Error, N/A Not Applicable as there was not enough data to fit ordinal logistic model

a Coefficient regression resulted from ordinal logistic regression model included bassline mRS as covariate